What is NDC 43386-030?

43386-030 is the product NDC for Monobasic Sodium Phosphate and Dibasic Sodium Phosphate, Sodium phosphate, Monobasic, Monohydrate 1.105 g/1; Sodium phosphate, Dibasic, Anhydrous .398 g/1 tablet, listed with the FDA by Lupin Pharmaceuticals,Inc..

What is the active ingredient?

Sodium phosphate, Monobasic, Monohydrate, Sodium phosphate, Dibasic, Anhydrous.

Lupin Pharmaceuticals,Inc., NDC labeler code 43386. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Monobasic Sodium Phosphate and Dibasic Sodium Phosphate?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

NDC 43386-030

NDC codes

FDA NDC Directory

Product NDC (as listed)43386-030Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43386-0030Add the package segment from the table below.

Product information

Brand name (proprietary): Monobasic Sodium Phosphate and Dibasic Sodium Phosphate
Generic name (nonproprietary): monobasic sodium phosphate and dibasic sodium phosphate
Active ingredients: Sodium phosphate, Monobasic, Monohydrate — 1.105 g/1Sodium phosphate, Dibasic, Anhydrous — .398 g/1
Dosage form: Tablet
Route: Oral
Labeler: Lupin Pharmaceuticals,Inc.NDC labeler code 43386
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 079247
Marketing start: Jan 20, 2012
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)
Identifiers: Product ID 43386-030_a1083256-d69a-4ff6-be4e-9719451792efSPL ID a1083256-d69a-4ff6-be4e-9719451792efSPL set ID e2fcc382-6fac-4438-ad02-ebc8528dd59aUNII 593YOG76RN, 22ADO53M6FUPC 0343386030019
Pharmacologic class: Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match: No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

Product label

Current FDA label (SPL), effective Jan 30, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Monobasic Sodium Phosphate and Dibasic Sodium Phosphate Tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults. Monobasic Sodium Phosphate and Dibasic Sodium Phosphate Tablets are an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 43386-030

What is NDC 43386-030?: 43386-030 is the product NDC for Monobasic Sodium Phosphate and Dibasic Sodium Phosphate, Sodium phosphate, Monobasic, Monohydrate 1.105 g/1; Sodium phosphate, Dibasic, Anhydrous .398 g/1 tablet, listed with the FDA by Lupin Pharmaceuticals,Inc..
What drug is associated with this NDC?: Monobasic Sodium Phosphate and Dibasic Sodium Phosphate.
What is the active ingredient?: Sodium phosphate, Monobasic, Monohydrate, Sodium phosphate, Dibasic, Anhydrous.
Who is the labeler?: Lupin Pharmaceuticals,Inc., NDC labeler code 43386. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Monobasic Sodium Phosphate and Dibasic Sodium Phosphate?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Monobasic Sodium Phosphate and Dibasic Sodium Phosphate NDC 43386-030